From: Systematic review of melanoma incidence and prognosis in solid organ transplant recipients
First author (publication year) | Population based | Location | Transplant data source | Number of patients with pre-transplant melanoma | Staging data (number of patients with data) | Post-transplant outcomes (number of patients) |
---|---|---|---|---|---|---|
Chapman[30] | Yes | Australia, New Zealand | ANZDATA | 19 | Not available | Recurrence (2) |
Brewer[20]a | No | United States | Mayo Clinic databases, OPTN, IPITTR (1967–2007), SEER | 59 | Breslow depth (15) | Median post-melanoma follow-up of 10.5 years: |
Local recurrence (0) | ||||||
Nodal metastasis (1) | ||||||
 |  |  |  |  |  | Lung metastasis (1) |
Matin[26] | No | Europe | SCOPE network (14 clinics) | 9 | Breslow depth (6) | No deaths after median post-melanoma follow-up of 14Â years |